Befoair

Befoair is a combination inhaler containing Beclometasone Dipropionate and Formoterol Fumarate Dihydrate, used for managing asthma and chronic obstructive pulmonary disease (COPD). This medication helps control symptoms and improve breathing.

Befoair is primarily used for the maintenance treatment of asthma and COPD. It combines an inhaled corticosteroid (Beclometasone Dipropionate) to reduce inflammation and a long-acting beta-agonist (Formoterol Fumarate Dihydrate) to relax the muscles in the airways. This dual-action approach helps manage symptoms such as wheezing, shortness of breath, and coughing. People often ask, 'What is Befoair used for?' and the answer is that it is designed to control and prevent symptoms rather than provide immediate relief during an asthma attack.

Common effects of Befoair may include throat irritation, hoarseness, and a dry mouth. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary. If any severe or persistent side effects occur, it is important to consult a healthcare provider.

Befoair should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of throat irritation and fungal infections. People with certain medical conditions, such as heart disease or diabetes, should discuss the use of Befoair with their doctor. Always store the inhaler properly and keep it out of reach of children.

Befoair may interact with other medications, including beta-blockers, which can reduce the effectiveness of the Formoterol component. It is also important to avoid using Befoair with other long-acting beta-agonists to prevent overstimulation of the airways. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.